Tested Applications
| Positive WB detected in | HeLa cells, HepG2 cells, L02 cells |
| Positive IP detected in | L02 cells |
| Positive IHC detected in | human ovary cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | U2OS cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:16000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20233-1-AP targets TOP2A-Specific in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rabbit |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | topoisomerase (DNA) II alpha 170kDa |
| Calculated Molecular Weight | 174 kDa |
| Observed Molecular Weight | 170-177 kDa |
| GenBank Accession Number | NM_001067 |
| Gene Symbol | TOP2A |
| Gene ID (NCBI) | 7153 |
| RRID | AB_10664923 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P11388 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TOP2A, also named as TOP2, belongs to the type II topoisomerase family. Topoisomerase II makes double-strand breaks. TOP2 control the topological states of DNA by transient breakage and subsequent rejoining of DNA strands. TOP2A may play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation. DNA topoisomerase IIa (170 kDa, TOP2a/170) is essential in proliferating cells by resolving DNA topological entanglements during chromosome condensation, replication, and segregation.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for TOP2A-Specific antibody 20233-1-AP | Download protocol |
| IHC protocol for TOP2A-Specific antibody 20233-1-AP | Download protocol |
| IP protocol for TOP2A-Specific antibody 20233-1-AP | Download protocol |
| WB protocol for TOP2A-Specific antibody 20233-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
TOP2A-Specific Polyclonal Antibody (catalog no. 20233-1-AP) has 35 citations. The journals include Science, Nature Communications, Nucleic Acids Research, J Exp Clin Cancer Res, Research, Int J Biol Sci, Mater Today Bio, Stem Cell Res Ther, J Cell Biol, Cells, and many others. The research fields span cancer biology (gastric, prostate, liver, renal, osteosarcoma, glioblastoma, and oral squamous cell carcinoma), DNA replication and topoisomerase II function, genome instability and chromatin organization, anti-tumor drug resistance and chemotherapy, cell cycle, stem cell biology, and liver disease/heart failure studies.
| Species | Application | Title |
|---|---|---|
Science Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. | ||
Nat Commun Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability | ||
Nat Commun Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. | ||
Nucleic Acids Res The SMC5/SMC6 complex is critical for resolving R-loop-induced transcription-replication conflicts. | ||
J Exp Clin Cancer Res 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. |









